#United States #New York #Class Action #Levi & Korsinsky #Walgreens

Overview

In an important notice for investors, Levi & Korsinsky, LLP has reminded shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) about the upcoming deadline for a lead plaintiff application in a class action lawsuit. This legal action aims to rectify losses incurred by shareholders due to alleged securities fraud occurring between April 2, 2020, and January 16, 2025.

Class Action Details

The lawsuit has emerged from concerns that despite the alleged commitment of Walgreens to regulatory compliance, the company faced serious violations related to federal laws governing prescription drugs. According to the filed complaint, several critical accusations have been made against the company:

1. False Statements: Walgreens allegedly conveyed misleading information regarding their compliance with regulatory standards.
2. Continued Violations: The company purportedly continued to engage in illegal activities linked to the distribution and reimbursement of prescription medications.
3. Risks of Scrutiny: The alleged practices have potentially exposed Walgreens to increased regulatory examination and civil liabilities.
4. Reputation and Revenue Risks: Reports suggest that the revenues derived from prescription sales may not be sustainable due to these unlawful practices, leading to significant reputational damage once details are revealed.

Next Steps for Investors

Investors who have experienced losses during this timeframe have a vital opportunity to engage by requesting to be named as the lead plaintiff. The deadline for such requests is March 31, 2025. It’s essential to note that participation in the class action does not necessitate taking on the role of lead plaintiff.

No Financial Burden

Importantly, shareholders involved in the class action may have the chance to receive compensation without the burden of upfront legal costs. There’s no obligation or fee required to participate, making it an accessible option for affected investors.

Why Choose Levi & Korsinsky?

With two decades of experience, Levi & Korsinsky has established a formidable reputation in shareholder advocacy, having secured hundreds of millions of dollars on behalf of investors in prior lawsuits. The firm specializes in intricate securities litigation and boasts an experienced team of over 70 professionals, focused on advancing clients' cases effectively. Recognized as one of the top securities litigation firms in the United States for seven consecutive years, their track record reflects their commitment to safeguarding investor rights.

Contact Information

For more information regarding participation in the class action or inquiries, investors can reach out through the following contact details:

• - Email: info@zlk.com
• - Phone: (212) 363-7500

Levi & Korsinsky, LLP 33 Whitehall Street, 17th Floor New York, NY 10004

Investors are encouraged to act swiftly to protect their interests as the deadline approaches. This class action presents an opportunity to hold accountable those responsible for the alleged deceptive practices affecting Walgreens stakeholders.